For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
Wu K.D. |
Wu K.D. |
Hsiao-Pao |
(06)5055433 |
2F.-1, No.9, Nanke 2nd Rd.,Xinshi Dist.,Tainan City 74146,Taiwan |
2024/03/29 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
OBM founded in December 2011, mainly aims at drug development. OBM firmly focuses on drugs for new combination products, new formulations, new indications and innovative controlled release drug systems. According to the section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act for non-New Chemical Entity (NCE), OBM has developed the drug carrier plan for new drugs. This plan will shorten the period of drug development for marketing and reduce the cost of capital and time. OBM also protects the products by patent application. The products are mainly constructed in two patent technologies - "nano composite technology platform micelles" and "trigger controlled release technology". These technologies will not only shorten time for drug development, but also make many drugs verging on failure to find their unique value during the process of drug development.
OBM aims to be a "Designer of Drug Delivery Systems" and a "Leader of global biopharmaceuticals in Taiwan". |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|